VISTIN PHARMA ASA (VISTN.OL) Stock Cash Flow
Europe - OSL:VISTN - NO0010734122 - Common Stock
23.7 NOK
+0.5 (+2.16%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 98.45M | 80.45M | 58.52M | -6.01M | 32.00M | |||
| Depreciation Amortization | 19.22M | 19.03M | 17.35M | 12.28M | 10.61M | |||
| Change In Working Capital | -14.94M | 8.37M | 14.73M | -16.78M | -28.92M | |||
| Interest Paid | N/A | 2.19M | 2.10M | 2.09M | 289.00K | |||
| Taxes Paid | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | N/A | N/A | N/A | N/A | N/A | |||
| OPERATING CASH FLOW | 102.73M | 107.86M | 90.59M | -10.51M | 13.68M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -23.10M | -40.80M | -17.90M | -64.29M | -31.94M | |||
| Other Investing Activity | N/A | 508.00K | 220.00K | 28.00K | 265.00K | |||
| INVESTING CASH FLOW | -22.59M | -40.30M | -17.68M | -64.26M | -31.68M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -1.20M | -46.05M | 42.55M | -836.00K | |||
| Stock Issued/Repurchased | N/A | N/A | N/A | N/A | N/A | |||
| Dividend Paid | -44.33M | -77.59M | 0.00 | 0.00 | -22.17M | |||
| Other Financing Activity | N/A | -2.19M | -2.10M | -2.09M | -289.00K | |||
| FINANCING CASH FLOW | -78.88M | -80.97M | -48.14M | 40.46M | -23.30M | |||
| CHANGE IN CASH | 1.26M | -13.41M | 24.77M | -34.31M | -41.29M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 102.73M | 107.86M | 90.59M | -10.51M | 13.68M | |||
| Capital Expenditure | -23.10M | -40.80M | -17.90M | -64.29M | -31.94M | |||
| FREE CASH FLOW | 79.64M | 67.05M | 72.69M | -74.80M | -18.26M | |||
All data in NOK